Institute of Science Tokyo Hospital
Bunkyō-Ku, Tokyo 113-8519
2 studies enrolling now · 3 studies all time
What they study most
Antiphospholipid Syndrome (APS), Behçet's Syndrome (BS), Bullous Pemphigoid (BP), CIDP, Chronic Inflammatory Demyelinating Polyneuropathy, Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Dermatomyositis (DM), Immune Thrombocytopenia (ITP), Immune-mediated Necrotizing Myopathy (IMNM), Intermediate Risk Non-Muscle Invasive Bladder Cancer
Studies at this site
- Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer — Recruiting now
- Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial) — Recruiting now
- A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP — Recruiting now